Literature DB >> 902001

Treatment of osteomalacia with oral 1-alpha-hydroxyvitamin D3 in a patient with malabsorption.

J E Compston, L W Horton, J R Tighe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 902001      PMCID： PMC1631566          DOI： 10.1136/bmj.2.6087.612

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  Advances in vitamin D metabolism as they pertain to chronic renal disease.

Authors:  J W Coburn; D L Hartenbower; A S Brickman
Journal:  Am J Clin Nutr       Date:  1976-11       Impact factor: 7.045

2.  Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine.

Authors:  M F Holick; H K Schnoes; H F DeLuca; T Suda; R J Cousins
Journal:  Biochemistry       Date:  1971-07-06       Impact factor: 3.162

3.  Response of adult patients with osteomalacia to treatment with crystalline 1alpha-hydroxy vitamin D3.

Authors:  P Bordier; M M Pechet; R Hesse; P Marie; H Rasmussen
Journal:  N Engl J Med       Date:  1974-10-24       Impact factor: 91.245
  3 in total
  2 in total

1.  Ultraviolet light: an effective treatment of osteomalacia in malabsorption.

Authors:  R T Jung; M Davie; J O Hunter; T M Chalmers
Journal:  Br Med J       Date:  1978-06-24

2.  Comparative absorption of vitamin D3 and 25-hydroxyvitamin D3 in intestinal disease.

Authors:  M Davies; E B Mawer; E L Krawitt
Journal:  Gut       Date:  1980-04       Impact factor: 23.059
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.